Detection and treatment of subclinical tuberculosis

Brian D. Robertson; Danny Altmann; Clif Barry; Bill Bishai; Stewart Cole; Dick Thomas Dick; Ken Duncan; Chris Dye; Sabine Ehrt; Hanif Esmail; Joanne Flynn; Richard Hafner; Gray Handley; Willem Hanekom; Paul Van Helden; Gilla Kaplan; Stefan H.E. Kaufmann; Peter Kim; Christian Lienhardt; Valerie Mizrahi; Eric Rubin; Dirk Schnappinger; David Sherman; Jelle Thole; Omar Vandal; Gerhard Walzl; Digby Warner; Robert Wilkinson; Douglas Young

doi:10.1016/j.tube.2012.06.004

Detection and treatment of subclinical tuberculosis

Brian D. Robertson, Danny Altmann, Clif Barry, Bill Bishai, Stewart Cole, Dick Thomas Dick, Ken Duncan, Chris Dye, Sabine Ehrt, Hanif Esmail, Joanne Flynn, Richard Hafner, Gray Handley, Willem Hanekom, Paul Van Helden, Gilla Kaplan, Stefan H.E. Kaufmann, Peter Kim, Christian Lienhardt, Valerie MizrahiEric Rubin, Dirk Schnappinger, David Sherman, Jelle Thole, Omar Vandal, Gerhard Walzl, Digby Warner, Robert Wilkinson, Douglas Young

Research output: Contribution to journal › Comment/debate › peer-review

29 Scopus citations

Abstract

Reduction of active disease by preventive therapy has the potential to make an important contribution towards the goal of tuberculosis (TB) elimination. This report summarises discussions amongst a Working Group convened to consider areas of research that will be important in optimising the design and delivery of preventative therapies. The Working Group met in Cape Town on 26th February 2012, following presentation of results from the GC11 Grand Challenges in Global Health project to discover drugs for latent TB.

Original language	English (US)
Pages (from-to)	447-452
Number of pages	6
Journal	Tuberculosis
Volume	92
Issue number	6
DOIs	https://doi.org/10.1016/j.tube.2012.06.004
State	Published - Nov 2012
Externally published	Yes

Keywords

Detection
Subclinical
Treatment
Tuberculosis

ASJC Scopus subject areas

Microbiology
Immunology
Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/j.tube.2012.06.004

Cite this

Robertson, B. D., Altmann, D., Barry, C., Bishai, B., Cole, S., Thomas Dick, D., Duncan, K., Dye, C., Ehrt, S., Esmail, H., Flynn, J., Hafner, R., Handley, G., Hanekom, W., Van Helden, P., Kaplan, G., Kaufmann, S. H. E., Kim, P., Lienhardt, C., ... Young, D. (2012). Detection and treatment of subclinical tuberculosis. Tuberculosis, 92(6), 447-452. https://doi.org/10.1016/j.tube.2012.06.004

Robertson, BD, Altmann, D, Barry, C, Bishai, B, Cole, S, Thomas Dick, D, Duncan, K, Dye, C, Ehrt, S, Esmail, H, Flynn, J, Hafner, R, Handley, G, Hanekom, W, Van Helden, P, Kaplan, G, Kaufmann, SHE, Kim, P, Lienhardt, C, Mizrahi, V, Rubin, E, Schnappinger, D, Sherman, D, Thole, J, Vandal, O, Walzl, G, Warner, D, Wilkinson, R & Young, D 2012, 'Detection and treatment of subclinical tuberculosis', Tuberculosis, vol. 92, no. 6, pp. 447-452. https://doi.org/10.1016/j.tube.2012.06.004

@article{8e61687de98a4c7ba447874585cd475e,

title = "Detection and treatment of subclinical tuberculosis",

abstract = "Reduction of active disease by preventive therapy has the potential to make an important contribution towards the goal of tuberculosis (TB) elimination. This report summarises discussions amongst a Working Group convened to consider areas of research that will be important in optimising the design and delivery of preventative therapies. The Working Group met in Cape Town on 26th February 2012, following presentation of results from the GC11 Grand Challenges in Global Health project to discover drugs for latent TB.",

keywords = "Detection, Subclinical, Treatment, Tuberculosis",

author = "Robertson, {Brian D.} and Danny Altmann and Clif Barry and Bill Bishai and Stewart Cole and {Thomas Dick}, Dick and Ken Duncan and Chris Dye and Sabine Ehrt and Hanif Esmail and Joanne Flynn and Richard Hafner and Gray Handley and Willem Hanekom and {Van Helden}, Paul and Gilla Kaplan and Kaufmann, {Stefan H.E.} and Peter Kim and Christian Lienhardt and Valerie Mizrahi and Eric Rubin and Dirk Schnappinger and David Sherman and Jelle Thole and Omar Vandal and Gerhard Walzl and Digby Warner and Robert Wilkinson and Douglas Young",

note = "Funding Information: The GC11 Grand Challenges in Global project was jointly funded by the Bill and Melinda Gates Foundation (37882) and The Wellcome Trust (077381). ",

year = "2012",

month = nov,

doi = "10.1016/j.tube.2012.06.004",

language = "English (US)",

volume = "92",

pages = "447--452",

journal = "Tuberculosis",

issn = "1472-9792",

publisher = "Churchill Livingstone",

number = "6",

}

TY - JOUR

T1 - Detection and treatment of subclinical tuberculosis

AU - Robertson, Brian D.

AU - Altmann, Danny

AU - Barry, Clif

AU - Bishai, Bill

AU - Cole, Stewart

AU - Thomas Dick, Dick

AU - Duncan, Ken

AU - Dye, Chris

AU - Ehrt, Sabine

AU - Esmail, Hanif

AU - Flynn, Joanne

AU - Hafner, Richard

AU - Handley, Gray

AU - Hanekom, Willem

AU - Van Helden, Paul

AU - Kaplan, Gilla

AU - Kaufmann, Stefan H.E.

AU - Kim, Peter

AU - Lienhardt, Christian

AU - Mizrahi, Valerie

AU - Rubin, Eric

AU - Schnappinger, Dirk

AU - Sherman, David

AU - Thole, Jelle

AU - Vandal, Omar

AU - Walzl, Gerhard

AU - Warner, Digby

AU - Wilkinson, Robert

AU - Young, Douglas

N1 - Funding Information: The GC11 Grand Challenges in Global project was jointly funded by the Bill and Melinda Gates Foundation (37882) and The Wellcome Trust (077381).

PY - 2012/11

Y1 - 2012/11

N2 - Reduction of active disease by preventive therapy has the potential to make an important contribution towards the goal of tuberculosis (TB) elimination. This report summarises discussions amongst a Working Group convened to consider areas of research that will be important in optimising the design and delivery of preventative therapies. The Working Group met in Cape Town on 26th February 2012, following presentation of results from the GC11 Grand Challenges in Global Health project to discover drugs for latent TB.

AB - Reduction of active disease by preventive therapy has the potential to make an important contribution towards the goal of tuberculosis (TB) elimination. This report summarises discussions amongst a Working Group convened to consider areas of research that will be important in optimising the design and delivery of preventative therapies. The Working Group met in Cape Town on 26th February 2012, following presentation of results from the GC11 Grand Challenges in Global Health project to discover drugs for latent TB.

KW - Detection

KW - Subclinical

KW - Treatment

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=84867335224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867335224&partnerID=8YFLogxK

U2 - 10.1016/j.tube.2012.06.004

DO - 10.1016/j.tube.2012.06.004

M3 - Comment/debate

C2 - 22819716

AN - SCOPUS:84867335224

SN - 1472-9792

VL - 92

SP - 447

EP - 452

JO - Tuberculosis

JF - Tuberculosis

IS - 6

ER -

Detection and treatment of subclinical tuberculosis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this